 Hypoxia-Inducible Factor-Proline Dioxygenases
"Hypoxia-Inducible Factor-Proline Dioxygenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dioxygenase enzymes that specifically hydroxylate a PROLINE residue on the HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. They are OXYGEN-dependent enzymes that play an important role in mediating cellular adaptive responses to HYPOXIA.
| Descriptor ID |
D064799
|
| MeSH Number(s) |
D08.811.682.690.416.617.500 D08.811.682.690.708.694.500
|
| Concept/Terms |
Hypoxia-Inducible Factor-Proline Dioxygenases- Hypoxia-Inducible Factor-Proline Dioxygenases
- Dioxygenases, Hypoxia-Inducible Factor-Proline
- Factor-Proline Dioxygenases, Hypoxia-Inducible
- Hypoxia Inducible Factor Proline Dioxygenases
- HIF Prolyl-4-Hydroxylases
- HIF Prolyl 4 Hydroxylases
- Prolyl-4-Hydroxylases, HIF
- Hypoxia-Inducible Factor-Proline Dioxygenase
- Dioxygenase, Hypoxia-Inducible Factor-Proline
- Factor-Proline Dioxygenase, Hypoxia-Inducible
- Hypoxia Inducible Factor Proline Dioxygenase
- HIF Prolyl-4-Hydroxylase
- HIF Prolyl 4 Hydroxylase
- Prolyl-4-Hydroxylase, HIF
|
Below are MeSH descriptors whose meaning is more general than "Hypoxia-Inducible Factor-Proline Dioxygenases".
Below are MeSH descriptors whose meaning is more specific than "Hypoxia-Inducible Factor-Proline Dioxygenases".
This graph shows the total number of publications written about "Hypoxia-Inducible Factor-Proline Dioxygenases" by people in this website by year, and whether "Hypoxia-Inducible Factor-Proline Dioxygenases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 | | 2021 | 0 | 2 | 2 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypoxia-Inducible Factor-Proline Dioxygenases" by people in Profiles.
-
Singh AK. Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO. Am J Nephrol. 2022; 53(5):361-365.
-
Singh AK, Carroll K, McMurray JJV, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Wiecek A, Blackorby A, Cizman B, Cobitz AR, Davies R, DiMino TL, Kler L, Meadowcroft AM, Taft L, Perkovic V. Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis. N Engl J Med. 2021 12 16; 385(25):2313-2324.
-
Singh AK, Carroll K, Perkovic V, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Wiecek A, Blackorby A, Cizman B, Cobitz AR, Davies R, Dole J, Kler L, Meadowcroft AM, Zhu X, McMurray JJV. Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. N Engl J Med. 2021 12 16; 385(25):2325-2335.
-
McMahon GM, Singh AK. Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 11; 28(6):600-606.
-
Zhu K, Song P, Lai Y, Liu C, Xiao G. Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts. Gene. 2016 Dec 05; 594(1):125-130.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|